ALLMedicine Unstable Angina Center

May 23rd, 2020 - Although the current western treatment plans for unstable angina (UA) has been optimized in past decades, UA still is a common phenotype of acute coronary syndrome and significantly influence the quality of life and endanger lives. In China, the c...

May 21st, 2020 - Ischaemic heart disease (IHD), in particular acute coronary syndrome (ACS), comprising ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and unstable angina, is the leading cause of death worldwide. Age is a major predicto...

May 15th, 2020 - Most allergic reactions to radiocontrast media can be managed with a pretreatment protocol of steroids and antihistamines. However, in rare circumstances, patients can have severe allergic symptoms despite pretreatment. In this case, we highlight ...

May 15th, 2020 - In coronary artery spasm (CAS), an excess coronary vasoconstriction causing total or subtotal vessel occlusion could lead to syncope, heart failure syndromes, arrhythmic syndromes, and myocardial ischemic syndromes including asymptomatic myocardia...

May 12th, 2020 - Cold hemagglutinin disease (CHAD) is a rare autoimmune disease, in which patients manifest symptoms when the body temperature decreases. It causes critical problems with blood clotting and hemolysis during hypothermia in cardiac surgery. Although ...

Jun 14th, 2019 - Purpose: To review the evidence and provide clinical recommendations for the screening and treatment of depression in patients who have had a recent acute coronary syndrome event. Methods: This guideline is based on a systematic review of randomi...

Apr 25th, 2019 - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Praluent® (alirocumab) to reduce the risk of heart attack, stroke and unstable angina requiring hospitalization...

Feb 28th, 2019 - LDL cholesterol (LDL-C) reduction with statins and PCSK9 inhibitors reduces risk of myocardial infarction (MI), but effects on specific types of MI are unknown. ODYSSEY OUTCOMES compared the PCSK9 inhibitor alirocumab (ALI) with placebo (PBO) in 1...

Feb 28th, 2019 - Background In time-to-first-event analyses, icosapent ethyl significantly reduced the risk of ischemic events, including cardiovascular death, among patients with elevated triglycerides receiving statins. These patients are at risk for not only fi...

Oct 31st, 2014 - These guidelines are intended to apply to adult patients with stable known or suspected ischemic heart disease (IHD), including those with new-onset chest pain (i. e.

May 23rd, 2020 - Although the current western treatment plans for unstable angina (UA) has been optimized in past decades, UA still is a common phenotype of acute coronary syndrome and significantly influence the quality of life and endanger lives. In China, the c...

May 21st, 2020 - Ischaemic heart disease (IHD), in particular acute coronary syndrome (ACS), comprising ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and unstable angina, is the leading cause of death worldwide. Age is a major predicto...

May 18th, 2020 - Clopidogrel bisulfate is a P2Y12 platelet inhibitor indicated for: Acute coronary syndrome For patients with non-ST-segment elevation ACS (unstable angina [UA]/non-ST-elevation myocardial infarction [NSTEMI]), clopidogrel bisulfate has been shown ...

May 15th, 2020 - Most allergic reactions to radiocontrast media can be managed with a pretreatment protocol of steroids and antihistamines. However, in rare circumstances, patients can have severe allergic symptoms despite pretreatment. In this case, we highlight ...

May 15th, 2020 - In coronary artery spasm (CAS), an excess coronary vasoconstriction causing total or subtotal vessel occlusion could lead to syncope, heart failure syndromes, arrhythmic syndromes, and myocardial ischemic syndromes including asymptomatic myocardia...

Feb 20th, 2020 - This transcript has been edited for clarity. My name is Mamas Mamas. I'm professor of cardiology based at Keele University. So, today we're going to talk about The National Institute for Health and Care Excellence (NICE) consultation document for ...

Nov 16th, 2019 - To Bernard Lown, MD: Sir, you are no longer a maverick. We should have listened to you. It took over 40 years, but today, at the American Heart Association (AHA) Scientific Sessions 2019, we learned that you were right to stop referring "most pati...

Nov 15th, 2019 - PHILADELPHIA — Viewed by many as the last chance to determine the true value of revascularization in stable ischemic heart disease, the ISCHEMIA trial failed to show fewer major cardiovascular events with an early invasive strategy than optimal me...

Aug 26th, 2019 - Patients at the highest risk derived the most benefit from aggressive lipid-lowering with PCSK9 inhibition, according to two analyses of the ODYSSEY OUTCOMES trial. Investigators previously showed that people randomized to receive alirocumab (Pral...

Aug 13th, 2019 - Measuring high-sensitivity cardiac troponin (hs-cTn) at presentation and after 1 hour not only identifies chest pain patients in the emergency department (ED) who are having an acute myocardial infarction (AMI), but also offers good prediction of ...